Status:

UNKNOWN

Fecal Microbiota Transplant (FMT) to Induce Weight Loss in Obese Subjects

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Obesity

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Obesity is associated with changes in the composition of the intestinal microbiota, and the obese microbiome appears to be more efficient in harvesting energy from the diet. Fecal microbiota transpla...

Detailed Description

Recently, accumulating evidence supports a role of the enteric microbiota in the pathogenesis of obesity-related insulin resistance. Obesity is associated with changes in the composition of the intest...

Eligibility Criteria

Inclusion

  • Age 18-75; and
  • BMI ≥28 kg/m\^2 and \< 45 kg/m\^2; and
  • Written informed consent obtained

Exclusion

  • Current pregnancy
  • Known history or concomitant significant gastrointestinal disorders (including Inflammatory Bowel Disease, current colorectal cancer)
  • Known history or concomitant significant food allergies
  • Immunosuppressed subjects
  • Known history of severe organ failure (including decompensated cirrhosis), kidney failure, epilepsy, acquired immunodeficiency syndrome
  • Current active sepsis
  • Known contraindications to oesophago-gastro-duodenoscopy (OGD)
  • Use of probiotic or antibiotics in recent 3 months
  • New drugs in the last three months that can impact on metabolism or body weight
  • Previous gastric or small intestinal surgery that alters gut anatomy such as fundoplication, gastric resection, gastric bypass, small bowel resection, ileoectomy, colectomy
  • Patients who have a confirmed current active malignancy or cancer

Key Trial Info

Start Date :

December 28 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03789461

Start Date

December 28 2018

End Date

December 1 2022

Last Update

February 14 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Chinese University of Hong Kong

Hong Kong, Hong Kong